Senl_B19 autologous CAR-T (S1904) treatment
COMPLETE
Unknown mab active
Quick answer
Senl_B19 autologous CAR-T (S1904) treatment for Relapsed Adult ALL is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Relapsed Adult ALL
- Phase
- Unknown
- Modality
- mab
- Status
- active